Evaluating Patient-Based Outcome Measures - NIHR Health ...

More documents

Recommendations

Info

54 References Eliasziw M, Donner A (1987). A cost–function approach to the design of reliability studies. Stat Med;6:647–55. Epstein AM (1990). The outcomes movement – will it get us where we want to go? N Engl J Med;323:266–70. Erickson P, Taeuber RC, Scott J (1995). Operational aspects of quality-of-life assessment: choosing the right instrument: review article. PharmacoEconomics;7:39–48. European Research Group on Health Outcomes Measures (1996). Choosing a health outcomes measurement instrument. Quality of Life Newsletter;6–7. Fallowfield LJ (1993). Quality of life measurement in breast cancer. J R Soc Med;86:10–12. Fallowfield LJ (1996). Quality of quality-of-life data. Lancet;348:421–2. Farquhar M (1994). The quality of life in older people. In: Quality of Life in Health Care (Albrecht G, Fitzpatrick R, editors). Connecticut: JAI Press. p. 139–58. Farquhar M (1995). Definitions of quality of life: a taxonomy. J Adv Nurs;22:502–8. Fava GA (1990). Methodological and conceptual issues in research on quality of life. Psychother Psychosom;54:70–6. Fayers PM, Hand D (1997). Factor analysis, causal indicators and quality of life. Qual Life Res;6:139–50. Fayers PM, Jones DR (1983). Measuring and analysing quality of life in cancer clinical trials: a review. Stat Med;2:429–46. Fayers PM, Machin D (1998). Factor analysis. In: Quality of life assessment in clinical trials (Staquet M, Hays R, Fayers P, editors). Oxford: Oxford University Press. p. 191–226. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R (1997). Quality of life assessment in clinical trials – guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur J Cancer;33:20–8. Feeny DH, Torrance GW (1989). Incorporating utilitybased quality-of-life assessment measures in clinical trials. Two examples. Med Care;27:S190–S204. Feeny DH, Furlong W, Boyle M, Torrance GW (1995). Multi-attribute health status classification systems: Health Utilities Index. PharmacoEconomics;7:490–502. Feinstein AR (1987). The theory and evaluation on sensibility. In: Clinimetrics (Feinstein AR, editor). New Haven: Yale University Press. p. 141–66. Feinstein AR (1992). Benefits and obstacles for development of health status assessment measures in clinical settings. Med Care;30:MS50–6. Feldstein ML (1991). Quality-of-life-adjusted survival for comparing cancer treatments. A commentary on TWiST and Q-TWiST. Cancer;67:851–4. Fitzpatrick R (1993). The measurement of health status and quality of life in rheumatological disorders. In: Psychological aspects of rheumatic disease (Newman S, Shipley M, editors). London: Bailliére Tindall. p. 297–317. Fitzpatrick R (1994). Applications of health status measures. In: Measuring health and medical outcomes (Jenkinson C, editor). London: University College London Press. p. 27–41. Fitzpatrick R (1996). Alternative approaches to the assessment of health-related quality of life. In: In pursuit of the quality of life (Offer A, editor). Oxford: Clarendon Press. p. 140–62. Fitzpatrick R, Albrecht G (1994). The plausibility of quality-of-life measures in different domains of health care. In: Concepts and measurement of quality of life in health care (Nordenfelt L, editor). Dordrecht: Kluwer Academic Publishers. p. 201–27. Fitzpatrick R, Newman S, Lamb R, Shipley M (1989). A comparison of measures of health status in rheumatoid arthritis. Br J Rheumatol;28:201–6. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A (1991). The social dimension of health status measures in rheumatoid arthritis. Int Disabil Stud;13:34–7. Fitzpatrick R, Fletcher AE, Gore SM, Jones D, Spiegelhalter DJ, Cox DR (1992). Quality of life measures in health care. I: applications and issues in assessment. BMJ;305:1074–7. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A (1993a). A comparison of the sensitivity to change of several health status instruments in rheumatoid arthritis. J Rheumatol;20:429–36. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A (1993b). Transition questions to assess outcomes in rheumatoid arthritis. Br J Rheumatol;32:807–11. Fletcher AE (1988). Measurement of quality of life in clinical trials of therapy. Recent Results Cancer Res;111:216–30. Fletcher AE, Hunt BM, Bulpitt CJ (1987). Evaluation of quality of life in clinical trials of cardiovascular disease. J Chronic Dis;40:557–69. Fletcher AE, Gore SM, Jones D, Fitzpatrick R, Spiegelhalter DJ, Cox DR (1992). Quality of life measures in health care. II: design, analysis and interpretation. BMJ;305:1145–8. Fowlie M, Berkeley J (1987). Quality of life – a review of the literature. Fam Pract;4:226–34. Frankel SJ (1991). The epidemiology of indications [editorial]. J Epidemiol Community Health;45:257–9. Fries JF (1983). Toward an understanding of patient outcome measurement. Arthritis Rheum;26:697–704. Froberg DG, Kane RL (1989a). Methodology for measuring health-state preferences – IV: progress and a research agenda. J Clin Epidemiol;42:675–85.
Froberg DG, Kane RL (1989b). Methodology for measuring health-state preferences – I: measurement strategies. J Clin Epidemiol;42:345–54. Froberg DG, Kane RL (1989c). Methodology for measuring health-state preferences – II: scaling methods. J Clin Epidemiol;42:459–71. Froberg DG, Kane RL (1989d). Methodology for measuring health-state preferences – III: population and context effects. J Clin Epidemiol;42:585–92. Gafni A (1994). The standard gamble method: what is being measured and how it is interpreted. Health Serv Res;29:207–24. Gafni A, Birch S (1993). Searching for a common currency: critical appraisal of the scientific basis underlying European harmonization of the measurement of health related quality of life (EuroQol). Health Policy;23:219–28. Ganiats TG, Palinkas LA, Kaplan RM (1992). Comparison of Quality of Well-Being scale and Functional Status Index in patients with atrial fibrillation. Med Care;30:958–64. Ganz PA, Moinpour CM, Cella DF, Fetting JH (1992). Quality-of-life assessment in cancer clinical trials: a status report [editorial]. J Natl Cancer Inst;84:994–5. Ganz PA (1994). Long-range effect of clinical trial interventions on quality of life. Cancer;74:2620–4. Gardiner PV, Sykes HR, Hassey GA, Walker DJ (1993). An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol;32:724–8. Garratt A, Ruta D, Abdalla M, Russell I (1994). SF-36 health survey questionnaire: II responsiveness to changes in health status in four common clinical conditions. Quality in Health Care;3:186–92. Gill TM, Feinstein AR (1994). A critical appraisal of the quality of quality-of-life measurements. JAMA;272:619–26. Gold M, Patrick DL, Torrance GW, et al (1996). Identifying and valuing outcomes. In: Cost-effectiveness in health and medicine (Gold M, Siegel J, Russell L, Weinstein M, editors). New York: Oxford University Press. p. 82–134. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992). Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst;84:575–9. Gough IR, Furnival CM, Schilder L, Grove W (1983). Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol;19:1161–5. Gower NH, Rudd RM, Ruiz de Elvira MC, Spiro SG, James LE, Harper PG, et al (1995). Assessment of ‘quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Ann Oncol;6:575–80. Health Technology Assessment 1998; Vol. 2: No. 14 Greenfield S, Nelson EC (1992). Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care;30:MS23–41. Groenvold M, Bjorner JB, Klee MC, Kreiner S (1995). Test for item bias in a quality of life questionnaire. J Clin Epidemiol;48:805–16. Guyatt GH (1995). A taxonomy of health status instruments. J Rheumatol;22:1188–90. Guyatt GH, Cook DJ (1994). Health status, quality of life and the individual. JAMA;272:630–31. Guyatt GH, Bombardier C, Tugwell P (1986). Measuring disease-specific quality of life in clinical trials. Can Med Assoc J;134:889–95. Guyatt GH, Townsend M, Berman LB, Keller JL (1987a). A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis;40:1129–33. Guyatt GH, Walter S, Norman GR (1987b). Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis;40:171–8. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A (1989a). Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol;42:403–8. Guyatt GH, Veldhuyzen van Zanten SJ, Feeny DH, Patrick DL (1989b). Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J;140:1441–8. Guyatt GH, Feeny DH, Patrick DL (1991). Issues in quality-of-life measurement in clinical trials. Control Clin Trials;12:81S–90S. Guyatt GH, Kirshner B, Jaeschke R (1992a). Measuring health status: what are the necessary measurement properties? J Clin Epidemiol;45:1341–5. Guyatt GH, Kirshner B, Jaeschke R (1992b). A methodologic framework for health status measures: clarity or oversimplification? J Clin Epidemiol;45:1353–5. Guyatt GH, Eagle DJ, Sackett B, Willan A, Griffith LE, McIlroy W, et al (1993a). Measuring quality of life in the frail elderly. J Clin Epidemiol;46:1433–4. Guyatt GH, Feeny DH, Patrick DL (1993b). Measuring health-related quality of life. Ann Intern Med;118:622–9. Hadorn DC, Uebersax J (1995). Large-scale health outcomes evaluation: how should quality of life be measured? Part I – Calibration of a brief questionnaire and a search for preference subgroups. J Clin Epidemiol;48:607–18. Hadorn DC, Hays RD, Uebersax J, Hauber T (1992). Improving task comprehension in the measurement of health state preferences. A trial of informational cartoon figures and a paired-comparison task. J Clin Epidemiol;45:233–43. Hadorn DC, Sorensen J, Holte J (1995). Large-scale health outcomes evaluation: how should quality of life be measured? Part II – Questionnaire validation in a cohort of patients with advanced cancer. J Clin Epidemiol;48:619–29. 55
Page 1 and 2:
Evaluating patient-based outcome me
Page 3:
HTA How to obtain copies of this an
Page 6 and 7:
NHS R&D HTA Programme The overall a
Page 9:
List of abbreviations Health Techno
Page 12 and 13:
iv Executive summary • These crit
Page 14 and 15:
2 Purpose and plan of this review t
Page 16 and 17: 4 What are patient-based outcome me
Page 22 and 23: 10 What are patient-based outcome m
Page 32 and 33: 20 Criteria for selecting a patient
Page 57: The rapid expansion of efforts to a
Page 60 and 61: 48 Recommendations further promote
Page 63 and 64: Aaronson NK (1989). Quality of life
Page 65: Clark A, Fallowfield LJ (1986). Qua
Page 69 and 70: Jenkinson C, Layte R, Wright L, Cou
Page 71 and 72: Mulley AG (1989). Assessing patient
Page 73 and 74: Shumaker S, Berzon RA (1995). The i
Page 75: Ware J, Bayliss MS, Rogers WH, Kosi
Page 78 and 79: 66 Appendix 1 Use inclusion and exc
Page 80 and 81: 68 Appendix 1 TABLE 5 Excluded sear
Page 83 and 84: Professor Senga Bond, University of
Page 85 and 86: Professor Mike Drummond, Centre for
show all

Evaluating Patient-Based Outcome Measures - NIHR Health ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?